Literature DB >> 6262862

Hepatitis B infection and primary liver cancer.

P Maupas, J L Melnick.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 6262862

Source DB:  PubMed          Journal:  Prog Med Virol        ISSN： 0079-645X


× No keyword cloud information.
  11 in total

1.  Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.

Authors:  G M Ginsberg; D Shouval
Journal:  J Epidemiol Community Health       Date:  1992-12       Impact factor: 3.710

2.  Hepatitis B virus suppresses expression of human beta-interferon.

Authors:  J S Twu; C H Lee; P M Lin; R H Schloemer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Induced underglycosylation of PLC/PRF/5 human hepatoma cells. Brief report.

Authors:  M Clementi; P Bagnarelli; P Pauri; M Brugia
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

4.  Hepatitis B virus DNA in human hepatocellular carcinoma: is the integration of hepatitis B virus DNA really carcinogenic?

Authors:  H Hada; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1986-12

5.  The epidemiology of primary liver cancer in a West German population: the Saarland.

Authors:  K Rimkus; G Dhom
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

6.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.

Authors:  Philip A Marsden; Qin Ning; Laisum S Fung; Xioping Luo; Yue Chen; Michael Mendicino; Anand Ghanekar; Jeremy A Scott; Teresa Miller; Camie W Y Chan; Mathew W C Chan; Wei He; Reginald M Gorczynski; David R Grant; David A Clark; M James Phillips; Gary A Levy
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients.

Authors:  S E Brown; C R Howard; M W Steward; A B Ajdukiewicz; H C Whittle
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

8.  Insulin reduces HBsAg production by PLC/PRF/5 human hepatoma cell line. Brief report.

Authors:  M Clementi; I Testa; P Bagnarelli; A Festa; P Pauri; M Brugia; L Calegari; C de Martinis
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

9.  Hepatitis B virus DNA in Kaposi sarcoma.

Authors:  A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  Hepatitis B Virus Core Promoter Double Mutations (A1762T, G1764A) Are Associated with Lower Levels of Serum Dihydrolipoyl Dehydrogenase.

Authors:  Zhi-Hua Jiang; Qin-Yan Chen; Tim J Harrison; Guo-Jian Li; Xue-Yan Wang; Hai Li; Li-Ping Hu; Kai-Wen Li; Qing-Li Yang; Chao Tan; Zhong-Liao Fang
Journal:  Intervirology       Date:  2016-06-16       Impact factor: 1.763
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.